Literature DB >> 17579061

CTL-associated antigen-4 ligation induces rapid T cell polarization that depends on phosphatidylinositol 3-kinase, Vav-1, Cdc42, and myosin light chain kinase.

Bin Wei1, Silvy da Rocha Dias, Hongyan Wang, Christopher E Rudd.   

Abstract

CTLA-4 can negatively regulate cytokine production and proliferation, increase motility, and override the TCR-induced stop-signal needed for stable T cell-APC conjugation. Despite this, little is known regarding whether CTLA-4 can alter T cell morphology and the nature of the signaling events that could account for this event. In this study, we demonstrate that anti-CTLA-4 and CD3/CTLA-4 induce rapid T cell polarization (i.e., within 15-30 min) with increases in lamellipodia, filopodia, and uropod formation. This was observed with anti-CTLA-4 and CD80-Ig ligation of CTLA-4, but not with anti-CD3 alone, or anti-CD3/CD28 coligation. Polarization required PI3K, the guanine nucleotide exchange factor Vav1, the GTP-binding protein Cdc42, as well as myosin L chain kinase. By contrast, a key downstream target of PI3K, protein kinase B, as well as Rho kinase and RhoA, were not needed. Our results demonstrate that CTLA-4 is a potent activator T cell polarization needed for motility, and this process involves specific set of signaling proteins that might contribute to coreceptor regulation of T cell function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579061     DOI: 10.4049/jimmunol.179.1.400

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  Memory T-cell trafficking: new directions for busy commuters.

Authors:  Federica M Marelli-Berg; Hongmei Fu; Fabrizio Vianello; Koji Tokoyoda; Alf Hamann
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 2.  T cell trafficking and metabolism: novel mechanisms and targets for immunomodulation.

Authors:  C Mauro; H Fu; F M Marelli-Berg
Journal:  Curr Opin Pharmacol       Date:  2012-03-20       Impact factor: 5.547

3.  PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.

Authors:  Colin M Segovis; Renee A Schoon; Christopher J Dick; Lucas P Nacusi; Paul J Leibson; Daniel D Billadeau
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

4.  CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization.

Authors:  Helga Schneider; Xin Smith; Hebin Liu; Georges Bismuth; Christopher E Rudd
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

5.  TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice.

Authors:  Jos Downey; Andrew Smith; Helga Schneider; Nancy Hogg; Christopher E Rudd
Journal:  Immunol Lett       Date:  2007-10-05       Impact factor: 3.685

6.  Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

Authors:  Maria Grazia Ruocco; Karsten A Pilones; Noriko Kawashima; Michael Cammer; Julie Huang; James S Babb; Mengling Liu; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

7.  Anti-CTLA4 Antibody Clinical Trials in Melanoma.

Authors:  Antoni Ribas
Journal:  Update Cancer Ther       Date:  2007-09

Review 8.  CD28 and CTLA-4 coreceptor expression and signal transduction.

Authors:  Christopher E Rudd; Alison Taylor; Helga Schneider
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

9.  IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells.

Authors:  B Wei; S Baker; J Wieckiewicz; K J Wood
Journal:  Am J Transplant       Date:  2009-11-04       Impact factor: 8.086

10.  Morphological change of CD4(+) T cell during contact with DC modulates T-cell activation by accumulation of F-actin in the immunology synapse.

Authors:  Wei Lin; Yuanzhen Suo; Yuting Deng; Zhichao Fan; Yijie Zheng; Xunbin Wei; Yiwei Chu
Journal:  BMC Immunol       Date:  2015-08-26       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.